EDGAR Filing Documents for 0000898432-08-000042

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000898432-08-000042

Filing Date

2008-01-28

Accepted

2008-01-29 07:28:24

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		dc985761v1memorypharmaceutic.htm	SC 13G	120074
	Complete submission text file	0000898432-08-000042.txt		122034

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address

Business Address 100 PHILIPS PARKWAY MONTVALE NJ 07645 2018027100

MEMORY PHARMACEUTICALS CORP (Subject) CIK: 0001062216 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-80464 | Film No.: 08555956
SIC: 2834 Pharmaceutical Preparations